{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:56:34Z","timestamp":1793908594614,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103450"],"award-info":[{"award-number":["82103450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373342"],"award-info":[{"award-number":["82373342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872057"],"award-info":[{"award-number":["81872057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52888-0","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:01:54Z","timestamp":1727798514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Chen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6217-8769","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-1695","authenticated-orcid":false,"given":"Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8059-6850","authenticated-orcid":false,"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-1884","authenticated-orcid":false,"given":"An-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"52888_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"52888_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"K Kao","year":"2022","unstructured":"Kao, K., Vilbois, S., Tsai, C. & Ho, P. Metabolic communication in the tumour-immune microenvironment. Nat. cell Biol. 24, 1574\u20131583 (2022).","journal-title":"Nat. cell Biol."},{"key":"52888_CR3","doi-asserted-by":"publisher","first-page":"108303","DOI":"10.1016\/j.pharmthera.2022.108303","volume":"240","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Liu, X., Huang, W., Liang, J. & Chen, Y. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment. Pharmacol. therapeutics 240, 108303 (2022).","journal-title":"Pharmacol. therapeutics"},{"key":"52888_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","volume":"16","author":"K Aldape","year":"2019","unstructured":"Aldape, K. et al. Challenges to curing primary brain tumours. Nat. Rev. Clin. Oncol. 16, 509\u2013520 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"52888_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"D Louis","year":"2016","unstructured":"Louis, D. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta neuropathologica 131, 803\u2013820 (2016).","journal-title":"Acta neuropathologica"},{"key":"52888_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.molmed.2021.07.011","volume":"27","author":"R Deshmukh","year":"2021","unstructured":"Deshmukh, R., Allega, M. & Tardito, S. A map of the altered glioma metabolism. Trends Mol. Med. 27, 1045\u20131059 (2021).","journal-title":"Trends Mol. Med."},{"key":"52888_CR7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel, E. et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell 181, 1626\u20131642.e1620 (2020).","journal-title":"Cell"},{"key":"52888_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer cell 42, 815\u2013832.e812 (2024).","journal-title":"Cancer cell"},{"key":"52888_CR9","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1158\/1078-0432.CCR-16-2598","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang, C. et al. Tumor purity as an underlying key factor in glioma. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 23, 6279\u20136291 (2017).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"52888_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan, D., Gutmann, D. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20\u201327 (2016).","journal-title":"Nat. Neurosci."},{"key":"52888_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","volume":"71","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis. Mol. cell 71, 201\u2013215.e207 (2018).","journal-title":"Mol. cell"},{"key":"52888_CR12","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic acids Res. 48, W509\u2013w514 (2020).","journal-title":"Nucleic acids Res."},{"key":"52888_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310163","volume":"11","author":"T Li","year":"2024","unstructured":"Li, T. et al. Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade. Adv. Sci. 11, e2310163 (2024).","journal-title":"Adv. Sci."},{"key":"52888_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer cell 32, 42\u201356.e46 (2017).","journal-title":"Cancer cell"},{"key":"52888_CR15","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. tissue-based map of the human proteome. Sci. (N. Y., NY) 347, 1260419 (2015).","journal-title":"Sci. (N. Y., NY)"},{"key":"52888_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.copbio.2020.11.013","volume":"68","author":"J Leca","year":"2021","unstructured":"Leca, J., Fortin, J. & Mak, T. Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers. Curr. Opin. Biotechnol. 68, 181\u2013185 (2021).","journal-title":"Curr. Opin. Biotechnol."},{"key":"52888_CR17","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101186R","volume":"35","author":"MK Montgomery","year":"2021","unstructured":"Montgomery, M. K. et al. Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice. FASEB J.: Off. Publ. Federation Am. Societies Exp. Biol. 35, e22046 (2021).","journal-title":"FASEB J.: Off. Publ. Federation Am. Societies Exp. Biol."},{"key":"52888_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/1673-5374.375328","volume":"19","author":"AA Shaimardanova","year":"2024","unstructured":"Shaimardanova, A. A. et al. Increasing \u03b2-hexosaminidase A activity using genetically modified mesenchymal stem cells. Neural regeneration Res. 19, 212\u2013219 (2024).","journal-title":"Neural regeneration Res."},{"key":"52888_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/anie.200804583","volume":"48","author":"K Stubbs","year":"2009","unstructured":"Stubbs, K., Macauley, M. & Vocadlo, D. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells. Angew. Chem. (Int. ed. Engl.) 48, 1300\u20131303 (2009).","journal-title":"Angew. Chem. (Int. ed. Engl.)"},{"key":"52888_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"J Koo","year":"2018","unstructured":"Koo, J. & Guan, K. Interplay between YAP\/TAZ and Metabolism. Cell Metab. 28, 196\u2013206 (2018).","journal-title":"Cell Metab."},{"key":"52888_CR21","doi-asserted-by":"publisher","first-page":"e1900162","DOI":"10.1002\/bies.201900162","volume":"42","author":"B Thompson","year":"2020","unstructured":"Thompson, B. YAP\/TAZ: drivers of tumor growth, metastasis, and resistance to therapy. BioEssays: N. Rev. Mol., Cell. developmental Biol. 42, e1900162 (2020).","journal-title":"BioEssays: N. Rev. Mol., Cell. developmental Biol."},{"key":"52888_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-004-9602-3","volume":"71","author":"Y Fujimoto","year":"2005","unstructured":"Fujimoto, Y. et al. Ganglioside GM3 inhibits proliferation and invasion of glioma. J. neuro-Oncol. 71, 99\u2013106 (2005).","journal-title":"J. neuro-Oncol."},{"key":"52888_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1242814","volume":"16","author":"NM Deschenes","year":"2023","unstructured":"Deschenes, N. M. et al. Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis. Front. Mol. Neurosci. 16, 1242814 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"52888_CR24","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.celrep.2017.02.041","volume":"18","author":"S Chakraborty","year":"2017","unstructured":"Chakraborty, S. et al. Agrin as a mechanotransduction signal regulating YAP through the Hippo pathway. Cell Rep. 18, 2464\u20132479 (2017).","journal-title":"Cell Rep."},{"key":"52888_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41556-018-0138-8","volume":"20","author":"EE Er","year":"2018","unstructured":"Er, E. E. et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat. cell Biol. 20, 966\u2013978 (2018).","journal-title":"Nat. cell Biol."},{"key":"52888_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165625","volume":"1866","author":"X Qin","year":"2020","unstructured":"Qin, X. et al. Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells. Biochimica et. biophysica acta Mol. basis Dis. 1866, 165625 (2020).","journal-title":"Biochimica et. biophysica acta Mol. basis Dis."},{"key":"52888_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tibs.2014.08.010","volume":"39","author":"C Sun","year":"2014","unstructured":"Sun, C. & Bernards, R. Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies. Trends biochemical Sci. 39, 465\u2013474 (2014).","journal-title":"Trends biochemical Sci."},{"key":"52888_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-018-0892-2","volume":"37","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Yes-associated protein (YAP) binds to HIF-1\u03b1 and sustains HIF-1\u03b1 protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. J. Exp. Clin. cancer Res. 37, 216 (2018).","journal-title":"J. Exp. Clin. cancer Res."},{"key":"52888_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"S Zhao","year":"2009","unstructured":"Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Sci. (N. Y., NY) 324, 261\u2013265 (2009).","journal-title":"Sci. (N. Y., NY)"},{"key":"52888_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-010-0790-y","volume":"121","author":"SC Williams","year":"2011","unstructured":"Williams, S. C. et al. R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1\u03b1 upregulation in adult glioma. Acta neuropathologica 121, 279\u2013281 (2011).","journal-title":"Acta neuropathologica"},{"key":"52888_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature10898","volume":"483","author":"P Koivunen","year":"2012","unstructured":"Koivunen, P. et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484\u2013488 (2012).","journal-title":"Nature"},{"key":"52888_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.molcel.2012.09.028","volume":"48","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. EGFR-induced and PKC\u03b5 monoubiquitylation-dependent NF-\u03baB activation upregulates PKM2 expression and promotes tumorigenesis. Mol. cell 48, 771\u2013784 (2012).","journal-title":"Mol. cell"},{"key":"52888_CR33","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ijc.30386","volume":"139","author":"E Madan","year":"2016","unstructured":"Madan, E. et al. FAT1 is a novel upstream regulator of HIF1\u03b1 and invasion of high grade glioma. Int. J. cancer 139, 2570\u20132582 (2016).","journal-title":"Int. J. cancer"},{"key":"52888_CR34","doi-asserted-by":"publisher","first-page":"67966","DOI":"10.18632\/oncotarget.11817","volume":"7","author":"RH de Wit","year":"2016","unstructured":"de Wit, R. H. et al. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1\u03b1\/PKM2 axis in glioblastoma cells. Oncotarget 7, 67966\u201367985 (2016).","journal-title":"Oncotarget"},{"key":"52888_CR35","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3171\/2018.12.JNS181798","volume":"132","author":"F Lan","year":"2019","unstructured":"Lan, F., Qin, Q., Yu, H. & Yue, X. Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity. J. Neurosurg. 132, 1456\u20131464 (2019).","journal-title":"J. Neurosurg."},{"key":"52888_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","volume":"42","author":"HJ Yun","year":"2023","unstructured":"Yun, H. J. et al. AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J. Exp. Clin. cancer Res.: CR 42, 340 (2023).","journal-title":"J. Exp. Clin. cancer Res.: CR"},{"key":"52888_CR37","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/s41388-022-02295-w","volume":"41","author":"J Wu","year":"2022","unstructured":"Wu, J. et al. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. Oncogene 41, 3024\u20133036 (2022).","journal-title":"Oncogene"},{"key":"52888_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.schres.2022.08.025","volume":"248","author":"H North","year":"2022","unstructured":"North, H., Weissleder, C., Fullerton, J., Webster, M. & Weickert, C. Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation. Schizophrenia Res. 248, 208\u2013218 (2022).","journal-title":"Schizophrenia Res."},{"key":"52888_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102046","volume":"49","author":"P Banerjee","year":"2020","unstructured":"Banerjee, P. et al. Generation of pure monocultures of human microglia-like cells from induced pluripotent stem cells. Stem cell Res. 49, 102046 (2020).","journal-title":"Stem cell Res."},{"key":"52888_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104511","volume":"150","author":"A Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab, A., Mahmoud, W. & Al-Harizy, R. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol. Res. 150, 104511 (2019).","journal-title":"Pharmacol. Res."},{"key":"52888_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","volume":"56","author":"A Poff","year":"2019","unstructured":"Poff, A. et al. Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin. cancer Biol. 56, 135\u2013148 (2019).","journal-title":"Semin. cancer Biol."},{"key":"52888_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K Sango","year":"1995","unstructured":"Sango, K. et al. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11, 170\u2013176 (1995).","journal-title":"Nat. Genet."},{"key":"52888_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0882-1","volume":"17","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. The role of YAP\/TAZ activity in cancer metabolic reprogramming. Mol. cancer 17, 134 (2018).","journal-title":"Mol. cancer"},{"key":"52888_CR44","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","volume":"34","author":"E Enzo","year":"2015","unstructured":"Enzo, E. et al. Aerobic glycolysis tunes YAP\/TAZ transcriptional activity. EMBO J. 34, 1349\u20131370 (2015).","journal-title":"EMBO J."},{"key":"52888_CR45","first-page":"1674","volume":"143","author":"A Elbediwy","year":"2016","unstructured":"Elbediwy, A. et al. Integrin signalling regulates YAP and TAZ to control skin homeostasis. Dev. (Camb., Engl.) 143, 1674\u20131687 (2016).","journal-title":"Dev. (Camb., Engl.)"},{"key":"52888_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3976","volume":"4","author":"I Serrano","year":"2013","unstructured":"Serrano, I., McDonald, P., Lock, F., Muller, W. & Dedhar, S. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat. Commun. 4, 2976 (2013).","journal-title":"Nat. Commun."},{"key":"52888_CR47","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.262816.115","volume":"29","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T. et al. A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 29, 1271\u20131284 (2015).","journal-title":"Genes Dev."},{"key":"52888_CR48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"52888_CR49","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1212\/WNL.0000000000002770","volume":"86","author":"W Cheng","year":"2016","unstructured":"Cheng, W. et al. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma. Neurology 86, 2226\u20132234 (2016).","journal-title":"Neurology"},{"key":"52888_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"N Butowski","year":"2016","unstructured":"Butowski, N. et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncol. 18, 557\u2013564 (2016).","journal-title":"Neuro-Oncol."},{"key":"52888_CR51","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1007\/s12035-016-0150-6","volume":"54","author":"W Cheng","year":"2017","unstructured":"Cheng, W. et al. Gene expression profiling stratifies IDH1-mutant glioma with distinct prognoses. Mol. Neurobiol. 54, 5996\u20136005 (2017).","journal-title":"Mol. Neurobiol."},{"key":"52888_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","volume":"20","author":"J Bi","year":"2020","unstructured":"Bi, J. et al. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets. Nat. Rev. Cancer 20, 57\u201370 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"52888_CR53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu, T. et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro-Oncol. 24, 1113\u20131125 (2022).","journal-title":"Neuro-Oncol."},{"key":"52888_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/0008-5472.CAN-08-1800","volume":"69","author":"SM Wiesner","year":"2009","unstructured":"Wiesner, S. M. et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 69, 431\u2013439 (2009).","journal-title":"Cancer Res."},{"key":"52888_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou, W. et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat. cell Biol. 17, 170\u2013182 (2015).","journal-title":"Nat. cell Biol."},{"key":"52888_CR56","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei, Y. et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat. cancer 4, 1273\u20131291 (2023).","journal-title":"Nat. cancer"},{"key":"52888_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15080","volume":"8","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat. Commun. 8, 15080 (2017).","journal-title":"Nat. Commun."},{"key":"52888_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s43018-023-00658-0","volume":"5","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism. Nat. cancer 5, 147\u2013166 (2024).","journal-title":"Nat. cancer"},{"key":"52888_CR59","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ccell.2022.10.015","volume":"40","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. CD16(+) fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition. Cancer cell 40, 1341\u20131357.e1313 (2022).","journal-title":"Cancer cell"},{"key":"52888_CR60","doi-asserted-by":"crossref","unstructured":"Chen X. et al. Molecular profiling identifies distinct subtypes across TP53 mutant tumors. JCI insight 7, (2022).","DOI":"10.1172\/jci.insight.156485"},{"key":"52888_CR61","first-page":"862","volume":"189","author":"W Remmele","year":"1993","unstructured":"Remmele, W. & Schicketanz, K. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-Assist. image Anal. (QIC score) vs. subjective grading (IRS). Pathol., Res. Pract. 189, 862\u2013866 (1993).","journal-title":"Computer-Assist. image Anal. (QIC score) vs. subjective grading (IRS). Pathol., Res. Pract."},{"key":"52888_CR62","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.7150\/thno.63202","volume":"11","author":"Q Liang","year":"2021","unstructured":"Liang, Q. et al. Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy. Theranostics 11, 9884\u20139903 (2021).","journal-title":"Theranostics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52888-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T17:02:58Z","timestamp":1727802178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52888-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52888"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52888-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8506"}}